Diabetes complications

A deep learning system for predicting time to progression of diabetic retinopathy

Nat MedPublished Prognostic model development and validation study

Authors' conclusion

Altogether, the DeepDR Plus system could predict individualized risk and time to DR progression over 5 years, potentially allowing personalized screening intervals.

Study context

Population
Participants with diabetes; pretraining 717,308 fundus images from 179,327 participants; training/validation multiethnic dataset of 118,868 images from 29,868 participants; real-world cohortstraining/validation dataset
Participants
29,868 participants
Outcome
Prediction of time to DR progression
Follow-up
Within 5 years
Methodological detailsdeep learning, multiethnic dataset, real-world validation cohorts, Pretrained on 717,308 fundus images from 179,327 participants with diabetes
  • Deep learning
  • Multiethnic dataset
  • Real-world validation cohorts
  • Pretrained on 717,308 fundus images from 179,327 participants with diabetes

Performance

As reported in the abstract

all times up to 5 years
Test or modelConcordance indexIntegrated Brier score
DeepDR Plus0.754-0.8460.153-0.241

DeepDR Plus

Concordance index0.754-0.846
Integrated Brier score0.153-0.241

Further findings

Real-world validation: integration with clinical workflow

Mean screening interval potentially extended from 12 months to
31.97 months
Participants recommended screening at 1-5 years, respectively
30.62%, 20.00%, 19.63%, 11.85% and 17.89%
Delayed detection of progression to vision-threatening diabetic retinopathy (DR)
0.18%
  • Real-world cohorts of participants with diabetes

Safety

Delayed detection of progression to vision-threatening DR
0.18%

Original publication

A deep learning system for predicting time to progression of diabetic retinopathy. Nat Med. Published 4 January 2024. doi:10.1038/s41591-023-02702-z

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.